Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

It's still a big question why they ended it now, particularly if Dew is right and it's unlikely they got anywhere near enough efficacy information to make a decision on that basis. If it was terminated based on the cost of the treatment, why now? Did the cost go up, or not go down as fast as they thought it would? Although I tend to discount this, it's possible they believe that HOT and NEO will have similar efficacy, and maybe HOT has much lower costs, so they bailed on NEO.